These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32276237)

  • 21. Lymphangioleiomyomatosis: a metastatic lung disease.
    Kundu N; Holz MK
    Am J Physiol Cell Physiol; 2023 Feb; 324(2):C320-C326. PubMed ID: 36571446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death.
    Shrestha S; Adib E; Imani J; Aguiar DJ; Lamattina AM; Tassew DD; Henske EP; Perrella MA; Priolo C; El-Chemaly S
    J Biol Chem; 2022 Nov; 298(11):102580. PubMed ID: 36220392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
    Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
    J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet.
    Gibbons E; Minor BMN; Hammes SR
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37410387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline.
    Obraztsova K; Basil MC; Rue R; Sivakumar A; Lin SM; Mukhitov AR; Gritsiuta AI; Evans JF; Kopp M; Katzen J; Robichaud A; Atochina-Vasserman EN; Li S; Carl J; Babu A; Morley MP; Cantu E; Beers MF; Frank DB; Morrisey EE; Krymskaya VP
    Nat Commun; 2020 Nov; 11(1):5640. PubMed ID: 33159078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis.
    Atochina-Vasserman EN; Guo CJ; Abramova E; Golden TN; Sims M; James ML; Beers MF; Gow AJ; Krymskaya VP
    Am J Respir Cell Mol Biol; 2015 Jul; 53(1):96-104. PubMed ID: 25474372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
    Goncharova EA; Krymskaya VP
    J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
    Steagall WK; Pacheco-Rodriguez G; Glasgow CG; Ikeda Y; Lin JP; Zheng G; Moss J
    Am J Pathol; 2013 Sep; 183(3):938-50. PubMed ID: 23867796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and molecular epidemiology of lymphangioleiomyomatosis and pulmonary pathology in tuberous sclerosis].
    Urban T
    Rev Mal Respir; 2000 Jun; 17(2 Pt 2):597-603. PubMed ID: 10939121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosis.
    Grzegorek I; Zuba-Surma E; Chabowski M; Janczak D; Szuba A; Dziegiel P
    Anticancer Res; 2015 Jun; 35(6):3341-51. PubMed ID: 26026094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation spectrums of TSC1 and TSC2 in Chinese women with lymphangioleiomyomatosis (LAM).
    Liu J; Zhao W; Ou X; Zhao Z; Hu C; Sun M; Liu F; Deng J; Gu W; An J; Zhang Q; Zhang X; Xie J; Li S; Chen R; Yu S; Zhong N
    PLoS One; 2019; 14(12):e0226400. PubMed ID: 31856217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in Polyamine Metabolism in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex 2-Deficient Cells.
    Tang Y; El-Chemaly S; Taveira-Dasilva A; Goldberg HJ; Bagwe S; Rosas IO; Moss J; Priolo C; Henske EP
    Chest; 2019 Dec; 156(6):1137-1148. PubMed ID: 31299246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.
    Chebib N; Archer F; Bobet-Erny A; Leroux C; Cottin V
    Sci Rep; 2018 Oct; 8(1):14698. PubMed ID: 30279475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling.
    Lin SM; Rue R; Mukhitov AR; Goel A; Basil MC; Obraztsova K; Babu A; Crnkovic S; Ledwell OA; Ferguson LT; Planer JD; Nottingham AN; Vanka KS; Smith CJ; Cantu E; Kwapiszewska G; Morrisey EE; Evans JF; Krymskaya VP
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38127441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary lymphangioleiomyomatosis.
    Zhang X; Travis WD
    Arch Pathol Lab Med; 2010 Dec; 134(12):1823-8. PubMed ID: 21128782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A second hit somatic (p.R905W) and a novel germline intron-mutation of TSC2 gene is found in intestinal lymphangioleiomyomatosis: a case report with literature review.
    Han B; Lee J; Kwak YJ; Kim HY; Lee KH; Shim Y; Lee H; Park SH
    Diagn Pathol; 2021 Aug; 16(1):83. PubMed ID: 34465349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM).
    Li F; Zhang Y; Lin Z; Yan L; Liu Q; Li Y; Pei X; Feng Y; Han X; Yang J; Zheng F; Li T; Zhang Y; Fu Z; Shao D; Yu J; Li C
    Cell Death Dis; 2022 Dec; 13(12):1065. PubMed ID: 36543771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.